MEIP - MEI Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MEI Pharma's activity chart (see below) currently has 28 price targets and 27 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 7.58% with an average time for these price targets to be met of 208.09 days.

Most recent stock forecast was given by YALE JEN from LAIDLAW on 23-Jul-2024.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 31-Aug-2018

$200

2 years 2 months 14 days ago
(23-Jul-2024)

1/2 (50%)

$135.06 (207.98%)

1503

Buy Since 12-Oct-2020

2 years 2 months 15 days ago
(22-Jul-2024)

0/7 (0%)

$6.62 (79.00%)

Hold Since 12-May-2023

$7

$3.93 (128.01%)

$7

2 years 5 months 25 days ago
(12-Apr-2024)

0/7 (0%)

$3.73 (114.07%)

Hold Since 08-Feb-2023

$2

$-1.07 (-34.85%)

$20

3 years 7 months 29 days ago
(08-Feb-2023)

1/3 (33.33%)

$-3.36 (-62.69%)

786

Hold Since 06-Dec-2022

$60

3 years 10 months 1 days ago
(06-Dec-2022)

0/3 (0%)

$50.2 (512.24%)

Show more analysts

Please expand the browser size to see the chart

What is MEIP (MEI Pharma) average time for price targets to be met?

On average it took 208 days for the stock forecasts to be reached, with an average price target met ratio of 7.58%.

Which analyst most recently updated their price target on MEIP (MEI Pharma)?

Yale Jen

Which analyst has the most public recommendations on MEIP (MEI Pharma)?

Yale Jen works at LAIDLAW and has 4 price targets and 3 ratings on MEIP

Which analyst is the currently most bullish on MEIP (MEI Pharma)?

Daniel Brims with the highest potential upside of $136.93

Which analyst is the currently most reserved on MEIP (MEI Pharma)?

Jim Birchenough with the lowest potential downside of -$1.54
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?